Filing Flows › Incyte (INCY) › R&D spending
Incyte (INCY) R&D spending by quarter
Incyte's R&D spending was $1.8B in Q3 2026 (third quarter 2026), +247% from Q2 2026. Over the last 5 quarters it ranged from $437M (Q1 2025) to $1.8B (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.8B | +247% | — |
| Q2 2026 | $517M | +0.2% | — |
| Q1 2026 | $516M | -16% | +18% |
| Q4 2025 | $611M | +40% | — |
| Q1 2025 | $437M | — | — |
Q3 2026 at a glance
Incyte, Q3 2026: revenue $1.6B (+14% year over year), operating margin -45.5%, net loss $785M, operating cash flow −$675M. The chart follows the revenue to costs, profit and cash.
Questions
What is Incyte's R&D spending?
Incyte's R&D spending was $1.8B in Q3 2026 (third quarter 2026), +247% from Q2 2026.
How has Incyte's R&D spending changed?
Over the last 5 quarters it ranged from $437M (Q1 2025) to $1.8B (Q3 2026).